Yerem Yeghiazarians, MD

Interventional cardiologist

Dr. Yerem Yeghiazarians is co-director of the Adult Cardiac Catheterization Laboratory, director of the Peripheral Interventional Cardiology Program and director of the UCSF Translational Cardiac Stem Cell Program. He is an expert in managing patients with coronary artery disease, acute coronary syndromes, valvular heart disease, cardiomyopathies, patent foramen ovale and peripheral arterial diseases.

Yeghiazarians earned an undergraduate degree from Brandeis University and a medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine at Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School, where he was chief medical resident and an instructor in medicine. He also completed general and interventional adult cardiology training at Brigham and Women's Hospital. At UCSF, he is a professor of cardiology.

Clinics

Cardiovascular Care and Prevention Center at Mission Bay
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Heart Valve Disease Clinic
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday through Friday, 8 a.m. – 5 p.m.

HHT Center of Excellence
185 Berry St., Suite 180, Lobby 6
San Francisco, CA 94107
Phone: (415) 353-8867
Fax: (415) 353-4503

Hours: Monday to Friday,
8 a.m. – 4:30 p.m.

Conditions & Treatments

Board Certification

Cardiovascular Disease, American Board of Internal Medicine
Interventional Cardiology, American Board of Internal Medicine

Academic Title

Professor

More about Yerem Yeghiazarians

Additional Languages

Armenian
French
Persian

Education

Johns Hopkins University School of Medicine 1995

Residencies

Brigham and Women's Hospital-Harvard Medical School, Internal Medicine 1998

Fellowships

Brigham and Women's Hospital-Harvard Medical School, Cardiology 2003

Selected Research and Publications

  1. Browne S, Jha AK, Ameri K, Marcus SG, Yeghiazarians Y, Healy KE. TGF-1/CD105 signaling controls vascular network formation within growth factor sequestering hyaluronic acid hydrogels. PLoS One. 2018; 13(3):e0194679.
  2. Geng X, Hwang J, Ye J, Shih H, Coulter B, Naudin C, Jun K, Sievers R, Yeghiazarians Y, Lee RJ, Boyle AJ. Aging is protective against pressure overload cardiomyopathy via adaptive extracellular matrix remodeling. Am J Cardiovasc Dis. 2017; 7(3):72-82.
  3. Ameri K, Samurkashian R, Yeghiazarians Y. Three-Dimensional Bioprinting: Emerging Technology in Cardiovascular Medicine. Circulation. 2017 Apr 04; 135(14):1281-1283.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.